ASH 2018 | A step towards next-generation immune monitoring in multiple myeloma?
VJHemOnc is committed to improving our service to you
Thanks for your feedback, this will help us improve our content for you!
Improved understanding of the tumor immune microenvironment (TIME) and its influence on response to therapy is needed. Here, Bruno Paiva, PhD, of the University of Navarra, Pamplona, Spain, discusses the phenotypic, molecular and functional profiling of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the TIME of multiple myeloma (MM). This revealed three unique subsets of G-MDSCs and a number of optimal markers for monitoring them, with important potential implications. This interview took place at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA.
Get great new content delivered to your inboxSign up